Summary
Mithramycin suppresses bone resorption. Its effect on the synthesis and release of β-glucuronidase (a referent for lysosomal enzymes) in mouse calvarial explants was studied in an in vitro culture system. A newly described medium (designated as KT medium) was introduced in this specific study. Mithramycin initially inhibited the release of β-glucuronidase into the medium and resulted in an ultimate accumulation of this enzyme in the bone. These results suggest that inhibition of bone resorption by mithramycin may be attributed to interference in release of lysosomal enzymes from bone cells.
Similar content being viewed by others
References
Parsons, V., Baum, M., Self, M.: Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease, Br. Med. J.1:474–477, 1967
Perlia, C.P., Gubisch, N.J., Wolter, J., Edelberg, D., Dederick, M.M., Taylor III, S.G.: Mithramycin treatment of hypercalcemia, Cancer25:389–394, 1970
Singer, F.R., Neer, R.M., Murray, T.M.: Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma, N. Engl. J. Med.283:634–636, 1970
Kiang, D.T., Kennedy, B.J.: Effect of mithramycin on the bone metabolism, Clin. Res.19:493, 1971
Cortes, E.P., Holland, J.F., Moskowitz, R., Depoli, E.: Effects of mithramycin on bone resorptionin vitro, Cancer Res.32:74–76, 1972
Minkin, C.: Inhibition of parathyroid hormone stimulated bone resorptionin vitro by the antibiotic mithramycin, Calcif. Tissue Res.13:249–257, 1973
Yarbro, J.W., Kennedy, B.J., Barnum, C.P.: Mithramycin inhibition of ribonucleic acid synthesis, Cancer Res.26:36–39, 1966
Kiang, D.T., Theologides, A., Lindall, A.W., Kennedy, B.J.: Effect of mithramycin on parathyroid hormone production in cancer patients, IRCS J. Med. Sci.3:612, 1975
Vaes, G.: On the mechanisms of bone resorption: the action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells. J. Cell. Biol.39:676–697, 1968
Vaes, G.: Lysosomes and the cellular physiology of bone resorption. In J.T. Dingle and H.B. Fell, (eds.): Lysosomes in Biology and Pathology, Vol. I, pp. 217–253. North-Holland Publishing Co., Amsterdam, 1969
Fell, H.B., Mellanby, E.: The effect of hypervitaminosis A on embryonic limb bones cultivatedin vitro, J. Physiol.116:320–349, 1952
Fell, H.B., Dingle, J.T.: Studies on the mode of action of excess of vitamin A. (6) Lysosomal protease and the degradation of cartilage matrix, Biochem. J.87:403–408, 1963
Reynolds, J.J.: Inhibition by calcitonin of bone resorption inducedin vitro by vitamin A, Proc. R. Soc. Biol.170:61–69, 1968
Reynolds, J.J., Dingle, J.T.: A sensitivein vitro method for studying the induction and inhibition of bone resorption, Calcif. Tissue Res.4:339–349, 1970
Plaice, C.H.J.: A note on the determination of serum β-glucuronidase activity, J. Clin. Pathol.14:661–665, 1961
Sutherland, E.W., Cori, C.F., Haynes, R., Olsen, N.S.: Purification of the hyperglycemic glycogenolytic factor from insulin and from gastric mucosa, J. Biol. Chem.180:825–837, 1949
Weissmann, G., Dingle, J.: Release of lysosomal protease by ultraviolet irradiation and inhibition by hydrocortisone, Exp. Cell Res.25:207–210, 1961
Vaes, G.: Inhibitory action of calcitonin on resorbing bone explants in culture and on their release of lysosomal hydrolases. J. Dent. Res. [Suppl.]51:362–366, 1972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kiang, D.T. Effect of mithramycin on boneβ-glucuronidase and resorption. Calc. Tis Res. 26, 209–213 (1978). https://doi.org/10.1007/BF02013260
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02013260